14 results on '"Mihm, U."'
Search Results
2. 799 EFFECTS OF RIBAVIRIN ON NK CELL PHENOTYPE AND FUNCTION IN HEPATITIS C VIRUS INFECTION
3. 1105 BASELINE CHARACTERISTICS CAN HELP TO PREDICT HEPATIC DECOMPENSATION DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND ADVANCED LIVER CIRRHOSIS
4. 1364 DEEP SEQUENCING REVEALS ACCUMULATION OF VIRAL VARIANTS IN HCV GENOTYPE 1 INFECTED PATIENTS DURING RIBAVIRIN MONOTHERAPY
5. 455 HCV VIRAL KINETICS DURING RIBAVIRIN MONOTHERAPY: RESULTS OF A RANDOMIZED PARTIALLY DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL
6. 259 ANTIVIRAL EFFICACY OF RIBAVIRIN MONOTHERAPY FOLLOWED BY STANDARD COMBINATION TREATMENT IN CHRONIC HEPATITIS C
7. 754 IMPACT OF RIBAVIRIN ON SUBGENOMIC HEPATITIS C VIRUS RNA DECAY DURING TREATMENT WITH INTERFERON ALFA AND THE PROTEASE INHIBITOR TELAPREVIR
8. 616 EFFECT OF RIBAVIRIN ON THE FREQUENCY OF RNASE L CLEAVAGE SITES WITHIN THE HEPATITIS C VIRAL GENOME
9. 709 LONG-TERM TREATMENT WITH LAMIVUDINE UP TO TEN YEARS: PREDICTIVE VALUE OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF HBV RESISTANCE
10. 738 BONE MINERAL DENSITY AND METABOLISM IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C
11. [521] MULTIFACTORIAL ANALYSIS OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF VIRAL RESISTANCE DURING LONG-TERM LAMIVUDINE TREATMENT OF HBV INFECTION OVER UP TO NINE YEARS
12. [430] RIBAVIRIN ACTS AS HEPATITIS C VIRUS MUTAGEN ON NONSTRUCTURAL 5B QUASISPECIES IN VITRO AND DURING ANTIVIRAL THERAPY
13. Significance of elevated IL8 levels in patients with chronic hepatitis C in comparison with patients with liver diseases of different origin
14. Detection of mutations necessary for HCV replication in the in vitro replicon system in patients with chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.